GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » ROIC %

Lexagene Holdings (Lexagene Holdings) ROIC % : -264.02% (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Lexagene Holdings's annualized return on invested capital (ROIC %) for the quarter that ended in Nov. 2022 was -264.02%.

As of today (2024-06-04), Lexagene Holdings's WACC % is 0.00%. Lexagene Holdings's ROIC % is 0.00% (calculated using TTM income statement data). Lexagene Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Lexagene Holdings ROIC % Historical Data

The historical data trend for Lexagene Holdings's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings ROIC % Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -862.91 -1,052.75 -411.80 -345.21 -366.97

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -318.50 -293.35 -296.62 -316.63 -264.02

Competitive Comparison of Lexagene Holdings's ROIC %

For the Medical Devices subindustry, Lexagene Holdings's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's ROIC % distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's ROIC % falls into.



Lexagene Holdings ROIC % Calculation

Lexagene Holdings's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Feb. 2022 is calculated as:

ROIC % (A: Feb. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Feb. 2021 ) + Invested Capital (A: Feb. 2022 ))/ count )
=-10.567 * ( 1 - 0% )/( (2.855 + 2.904)/ 2 )
=-10.567/2.8795
=-366.97 %

where

Lexagene Holdings's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Nov. 2022 is calculated as:

ROIC % (Q: Nov. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2022 ) + Invested Capital (Q: Nov. 2022 ))/ count )
=-6.644 * ( 1 - 0% )/( (2.466 + 2.567)/ 2 )
=-6.644/2.5165
=-264.02 %

where

Note: The Operating Income data used here is four times the quarterly (Nov. 2022) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lexagene Holdings  (OTCPK:LXXGQ) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Lexagene Holdings's WACC % is 0.00%. Lexagene Holdings's ROIC % is 0.00% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Lexagene Holdings ROIC % Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.